-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to statistics, the current part of advanced malignancies, patients five-year survival rate of less than 20%, but if early prevention, early detection, early treatment, patients 5 years survival rate can be as high as 80%, how early prevention? In 2013, Angelina Jolie's decision to remove her bilateral breasts after testing confirmed a mutation carrying the BRCA1 gene sparked a wave of concern about genetic testing.
" genetic testing can be applied to the risk assessment of tumors and genetic diseases, and the results of genetic tests are of great help to clinicians in their diagnosis and medication.
1, genetic testing "digs out" disease susceptibility genes" in the human body, the presence of some genotypes, increase the risk of certain diseases, this gene is called disease susceptibility gene.
genetic testing, you can understand individual genetic defects, identify disease susceptibility genes, and develop the best health care methods and lifestyles in advance in accordance with scientific health assessments, so as to minimize the avoidance and prevention of major diseases.
"for susceptibility genes, targeted physical examination and health management, can be more to prevent disease, individual protection, such as a person's genetic tests show the presence of tumor susceptibility gene genotype, then in the future health check-up should strengthen the tumor screening and related indicators of the examination.
is understood that genetic testing is the human genetic material DNA testing, so it can be in the first few years or even decades of disease symptoms to predict, assess the risk of disease.
2, people with a family history of cancer can carry out cancer risk assessment" does not encourage all people to carry out genetic sequencing, but if there is a family history of the tumor, two or more people in immediate family members of the same type of tumor or the same type of tumor, it is recommended that the corresponding genetic tumor genetic testing can be carried out to confirm and assess the risk of cancer in the entire family.
"infer the probability of developing a disease in the future by determining the sequence of genes known to be associated with it."
, ovarian cancer, stomach cancer, colorectal cancer, nasopharyngeal cancer, neuroblastoma, childhood tumors and other tumors of these tumors have a more obvious genetic susceptibility, suitable for genetic testing and assessment of risk.
3, genetic testing to identify whether patients are suitable for the emergence of targeted drugs, so that many tumor patients' survival rate has been significantly improved, and its main effect on the patient's body variant genes, genetic testing, by determining certain genes (e.g. e.g. e.g. lung cancer EGFR mutation and kraS mutation of bowel cancer), to determine the target drug target, in a series of drugs or treatment options to find the most effective drug or treatment program for specific patients to avoid the effectiveness of the drug
4, the gene test inglion into the medical insurance no doubt, genetic testing will play an increasingly important role in the future medical diagnosis and treatment, for malignant tumors in advance "risk assessment" will save patients a lot of money for follow-up treatment, but also to alleviate the shortage of medical resources.
the prevention and treatment of tumors to forward resources, to "prevent" mainly.
calls for the screening of cancer prevention screening and clinically significant cancer susceptibility genetic testing in healthy populations to improve the early detection and early cure rate of cancer.
" this would allow more people to treat early, both health and save valuable medical resources.
"Source: Decoding Medicine.